Global Power-Over-Ethernet (PoE) Chipsets Market to Reach $2.3 Billion by 2030
The global market for Power-Over-Ethernet (PoE) Chipsets estimated at US$1.7 Billion in the year 2022, is projected to reach a revised size of US$2.3 Billion by 2030, growing at a CAGR of 3.7% over the analysis period 2022-2030. Powered Devices (PD) Chipset, one of the segments analyzed in the report, is projected to record 5.9% CAGR and reach US$1.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Power Sourcing Equipment (PSE) Chipset segment is readjusted to a revised 1% CAGR for the next 8-year period.The U.S. Market is Estimated at $466.5 Million, While China is Forecast to Grow at 2.9% CAGR
The Power-Over-Ethernet (PoE) Chipsets market in the U.S. is estimated at US$466.5 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$368.5 Million by the year 2030 trailing a CAGR of 2.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.9% and 0.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately -0.8% CAGR.Select Competitors (Total 39 Featured) -
- AbbVie, Inc.
- Acerus Pharmaceuticals Corporation
- Acrux Limited
- Antares Pharma, Inc.
- Bayer HealthCare Pharmaceuticals
- Eli Lilly and Company
- Endo Pharmaceuticals Inc.
- Kyowa Kirin
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie, Inc.
- Acerus Pharmaceuticals Corporation
- Acrux Limited
- Antares Pharma, Inc.
- Bayer HealthCare Pharmaceuticals
- Eli Lilly and Company
- Endo Pharmaceuticals Inc.
- Kyowa Kirin
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 272 |
Published | May 2024 |
Forecast Period | 2020 - 2027 |
Estimated Market Value ( USD | $ 1.3 Billion |
Forecasted Market Value ( USD | $ 3 Billion |
Compound Annual Growth Rate | 12.7% |
Regions Covered | Global |